Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Absolute Bioavailability Study of LY3039478 in Healthy Subjects Using the Intravenous Tracer Method

NCT02906618 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT02906618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02906618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Absolute Bioavailability Study of LY3039478 in Healthy Subjects Using the Intravenous Tracer Method
Lead sponsor
Eli Lilly and Company
Phase
Phase 1
Overall status
Completed
Start date
October 4, 2016
Completion date
November 11, 2016
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy